Dr Reddys Laboratories Share Price Today - Live Blog for August 18, 2025

The stock of Dr Reddys Laboratories Ltd suffered a -0.00% decline, and it currently trades at ₹1,261.60 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

Dr Reddys Laboratories Ltd's share price has fallen by -0.08%, a situation worth noting. At present, the stock is trading at ₹1,261.90. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 18.5000, while the industry PE ratio is 34.8520.

Dr Reddys Laboratories Ltd witnessed a notable 0.08% surge in its share price and is presently trading at ₹1,261.80, captivating the attention of market participants.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.08%, reaching the current market price of ₹1,261.10. This ascent signifies increased investor sentiment. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's share price has fallen by -0.23%, a situation worth noting. At present, the stock is trading at ₹1,260.10. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 18.5000, while the industry PE ratio is 34.8520.

After a significant 0.23% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,263.00 in the current market. This upward movement is attracting attention from both retail and institutional investors.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.18% gain, with the share price now at ₹1,260.15. Notably, the stock's PE ratio stands at 18.5000, and its Return on Equity (ROE) is 16.8559%.

Dr Reddys Laboratories Ltd experienced a substantial 0.29% boost in its share price and has garnered significant attention from the market. It's now trading at ₹1,258.70, making it an appealing option for investors.

Dr Reddys Laboratories Ltd observed a remarkable 0.48% surge in its share price and is presently trading at ₹1,255.05. The increased investor interest is driving this surge.

Dr Reddys Laboratories Ltd's stock has risen by a substantial 0.11%, and as of now, it's trading at ₹1,248.95 per share. This upward trajectory is attracting keen interest from investors.

With a -0.01% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,247.60. The stock is currently trading at a PE of 18.5000, while the industry PE is 34.8520, prompting investors to assess its value proposition.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.10% drop, and it's now trading at ₹1,246.10 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.14% upswing, and it's currently trading at ₹1,244.90 per share. Investors are closely watching this development.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.01% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at ₹1,242.75 per share. The stock has an ROE of 16.8559% and debt to equity ratio of 0.1394.

Increased investor interest has propelled Dr Reddys Laboratories Ltd's stock to a significant 0.01% gain, with the share price now at ₹1,242.75. Notably, the stock's PE ratio stands at 18.5000, and its Return on Equity (ROE) is 16.8559%.

Dr Reddys Laboratories Ltd shares experienced a -0.34% reduction, with the current market price at ₹1,249.25. Investors are carefully considering their positions and seeking insights into the stock's future performance.

Dr Reddys Laboratories Ltd shares saw a decrease of -0.34%, reaching a current market price of ₹1,249.25. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Dr Reddys Laboratories Ltd experienced a -0.51% dip in its share price and is currently trading at ₹1,253.40. The stock has a PE ratio of 18.5000, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

The stock of Dr Reddys Laboratories Ltd is facing a -0.13% decline and is currently trading at ₹1,259.70 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

The stock of Dr Reddys Laboratories Ltd suffered a -0.17% drop, and it's now trading at ₹1,261.40 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

The stock of Dr Reddys Laboratories Ltd suffered a -0.19% decline, and it currently trades at ₹1,258.15 per share. Investors are closely monitoring this situation, looking for potential signs of recovery.

With a -0.19% decrease, Dr Reddys Laboratories Ltd's share price is currently at ₹1,258.15. This development raises questions about the factors behind the decline. The stock's PE ratio is 18.5000, while the industry PE is 34.8520.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.03%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,261.40 per share.

Dr Reddys Laboratories Ltd's share price has dropped by -0.09%, a development that warrants careful analysis. Presently trading at ₹1,261.00, investors are assessing whether this presents an opportunity or a risk.

The share price of Dr Reddys Laboratories Ltd experienced a -2.80% slump and is currently trading at ₹1,258.15. While the stock maintains a PE ratio of 18.5000, the industry PE is 34.8520, raising questions about valuation.

The share price of Dr Reddys Laboratories Ltd has plummeted by -2.80%, signalling a challenging period. Currently trading at ₹1,258.15, this stock has caught the eye of bargain hunters, who may be considering their entry points.